|
PHOSPHO2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63343999999288E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.107800E-01 |
| Normal-vs-Stage2 |
2.301200E-01 |
| Normal-vs-Stage3 |
6.25269999998679E-07 |
| Normal-vs-Stage4 |
2.28139729330223E-12 |
| Stage1-vs-Stage2 |
5.496000E-01 |
| Stage1-vs-Stage3 |
5.79640000000214E-05 |
| Stage1-vs-Stage4 |
2.33639996238821E-10 |
| Stage2-vs-Stage3 |
3.788500E-02 |
| Stage2-vs-Stage4 |
1.121760E-03 |
| Stage3-vs-Stage4 |
8.693800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80318999999374E-05 |
| Normal-vs-AfricanAmerican |
4.122500E-03 |
| Normal-vs-Asian |
4.855400E-01 |
| Caucasian-vs-AfricanAmerican |
7.337400E-01 |
| Caucasian-vs-Asian |
8.692800E-01 |
| AfricanAmerican-vs-Asian |
7.446200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16160000016319E-07 |
| Normal-vs-Female |
4.041800E-02 |
| Male-vs-Female |
5.813700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.75400000000226E-05 |
| Normal-vs-Age(41-60Yrs) |
1.040290E-03 |
| Normal-vs-Age(61-80Yrs) |
1.975420E-04 |
| Normal-vs-Age(81-100Yrs) |
2.849800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.703800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.084100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.318100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.315400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.604000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.676600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.072800E-01 |
| Normal-vs-Grade 2 |
3.959000E-01 |
| Normal-vs-Grade 3 |
3.54139999991787E-07 |
| Normal-vs-Grade 4 |
4.10149691987272E-12 |
| Grade 1-vs-Grade 2 |
5.503000E-01 |
| Grade 1-vs-Grade 3 |
3.134400E-02 |
| Grade 1-vs-Grade 4 |
2.229600E-04 |
| Grade 2-vs-Grade 3 |
2.644800E-04 |
| Grade 2-vs-Grade 4 |
5.64919999668234E-10 |
| Grade 3-vs-Grade 4 |
3.178200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.079900E-02 |
| Normal-vs-ccB subtype |
3.5527136788005E-15 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.422830E-04 |
| Normal-vs-N1 |
1.87883042457315E-12 |
| N0-vs-N1 |
4.45029999962543E-07 |
|
|
